Douglas E. Feltner - Concepedia

Author

Douglas E. Feltner

Also Known As

D E Feltner, D FELTNER, D Feltner, D. Feltner, D.E. Feltner, DOUGLAS FELTNER, Douglas E Feltner, Douglas E. Feitner, Douglas E. Feltner, Douglas Feltner

112

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Michigan Nationwide Children's Hospital The Ohio State University Novartis (United States)

About

Douglas E. Feltner is an author at Pfizer (United States) specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	2.3K
2	Social Sciences	8	8	887
3	Natural Sciences	3	3	166
4	Health Sciences	2	2	60
5	Behavioral Sciences	1	1	12

Douglas E. Feltner

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic Dietmar Bengel, Dennis L. Murphy, Anne M. Andrews, Molecular Pharmacology	1998	710
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. Wayne A. Marasco, Sem H. Phan, Henry C. Krutzsch, Journal of Biological Chemistry BiosynthesisFormyl PeptidesBiochemistryNh2-terminal Formyl PeptidesChemotactic Factor	1984	524
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial John Day, Richard S. Finkel, Claudia A. Chiriboga, The Lancet Neurology Rare DiseasesSpinal Cord InjuryMedicineDegenerative DiseaseNeurology	2021	449
Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial Atul C. Pande, Jerri G. Crockatt, Douglas E. Feltner, American Journal of Psychiatry	2003	315
Vocal Acoustic Biomarkers of Depression Severity and Treatment Response James C. Mundt, Adam P. Vogel, Douglas E. Feltner, Biological Psychiatry PsychiatryMood SymptomVocal Acoustic BiomarkersPathological SpeechDepression	2012	313
Pregabalin for Treatment of Generalized Anxiety Disorder Karl Rickels, Mark H. Pollack, Douglas E. Feltner, Archives of General Psychiatry Psychotropic MedicationNeuromodulation TherapiesPsychopharmacologyPharmacotherapyAlprazolam Groups	2005	279
Psychometric evaluation of a visual analog scale for the assessment of anxiety Valerie Williams, Robert Morlock, Douglas E. Feltner Health and Quality of Life Outcomes	2010	271
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study of Pregabalin in Patients With Generalized Anxiety Disorder Douglas E. Feltner, Jerri G. Crockatt, Steven J. Dubovsky, Journal of Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	2003	259
A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH <sub>1</sub> Antagonist) in the Treatment of Major Depression Brendon Binneman, Douglas E. Feltner, Sheela Kolluri, American Journal of Psychiatry	2008	248
Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder Louis S. Matza, Robert Morlock, Christopher Sexton, International Journal of Methods in Psychiatric Research	2010	244

Page 1